by rameyrobo | Feb 7, 2021
About Us Meet Prolong Pharmaceuticals Prolong Pharmaceuticals, LLC (Prolong) is a clinical-stage biopharmaceutical company focused on identifying, developing, and commercializing differentiated products that treat prevalent conditions and address unmet medical needs...
by rameyrobo | Jan 20, 2021
Publications & News Stay Up-To-Date with Prolong Pharmaceuticals Publications Targeting the Heme Oxygenase 1/Carbon Monoxide Pathway to Resolve Lung Hyper-Inflammation and Restore a Regulated Immune Response in Cystic Fibrosis. Jul, 2020 Microvascular and Systemic...
by rameyrobo | Jan 15, 2021
Pipeline Our Products Phase Chart for Clinical Pipeline for PP-007 PP-007 (SANGUINATE®, PEGylated carboxyhemoglobin bovine) Prolong’s lead biopharmaceutical pipeline candidate is PEGylated carboxyhemoglobin bovine (PCHB). PP-007 unique mechanisms arise from its...
by rameyrobo | Jan 14, 2021
Our Team Investors and Industry Leaders Our leadership team has led and been associated with several successful pharmaceutical and biotechnology companies. Our founders brought over 50 years experience to our laboratories and delivered a novel PEGylation method....
by rameyrobo | Jan 12, 2021
Team Member Position / Title Lorem ipsum dolor sit amet, consectetur adipiscing elit. Curabitur tincidunt mollis ante non volutpat. Nam consequat diam nec leo rutrum tempus. Nulla accumsan eros nec sem tempus scelerisque. Morbi tincidunt risus magna, posuere lobortis...
